CNGB3-Achromatopsia Clinical Trial With CNTF: Diminished Rod Pathway Responses With No Evidence of Improvement in Cone Function. [electronic resource]
- Investigative ophthalmology & visual science Mar 2015
- 1505 p. digital
Publication Type: Letter; Comment
1552-5783
10.1167/iovs.14-15897 doi
Ciliary Neurotrophic Factor--administration & dosage Color Vision Defects--drug therapy Cyclic Nucleotide-Gated Cation Channels--metabolism Female Humans Male Retinal Rod Photoreceptor Cells--physiology